161 related articles for article (PubMed ID: 18618361)
1. Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases.
Antonucci A; Bardazzi F; Balestri R; Patrizi A
J Dermatolog Treat; 2009; 20(1):61-2. PubMed ID: 18618361
[TBL] [Abstract][Full Text] [Related]
2. Efalizumab-associated papular psoriasis.
Hassan AS; Simon D; Simon HU; Braathen LR; Yawalkar N
Arch Dermatol; 2007 Jul; 143(7):900-6. PubMed ID: 17638735
[TBL] [Abstract][Full Text] [Related]
3. Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris.
de Groot M; de Rie MA; Bos JD
Br J Dermatol; 2005 Oct; 153(4):843-4. PubMed ID: 16181475
[No Abstract] [Full Text] [Related]
4. Psoriasiform drug eruption due to abatacept.
Kato K; Satoh T; Nishizawa A; Yokozeki H
Acta Derm Venereol; 2011 May; 91(3):362-3. PubMed ID: 21336469
[No Abstract] [Full Text] [Related]
5. Efalizumab-induced thrombocytopenia: report of relapse after re-administration.
Kiorpelidou D; Tsiouri G; Gaitanis G; Akritidis N; Bassukas ID
Clin Exp Dermatol; 2009 Dec; 34(8):e914-6. PubMed ID: 20055866
[TBL] [Abstract][Full Text] [Related]
6. Development of monoclonal gammopathy in 12 patients receiving efalizumab treatment for chronic plaque psoriasis.
Prignano F; Pescitelli L; Ricceri F; Ermini A; Lotti T
J Am Acad Dermatol; 2010 Oct; 63(4):e84-7. PubMed ID: 20846561
[No Abstract] [Full Text] [Related]
7. Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series.
Lowes MA; Chamian F; Abello MV; Leonardi C; Dummer W; Papp K; Krueger JG
BMC Dermatol; 2007 Feb; 7():2. PubMed ID: 17324275
[TBL] [Abstract][Full Text] [Related]
8. DRESS syndrome caused by efalizumab.
White JM; Smith CH; Robson A; Ash G; Barker JN
Clin Exp Dermatol; 2008 Jan; 33(1):50-2. PubMed ID: 18021270
[TBL] [Abstract][Full Text] [Related]
9. Infliximab-induced acne: a new case and review of published reports.
Steels E; Peretz A; Vereecken P
J Dermatolog Treat; 2009; 20(1):59-60. PubMed ID: 18608731
[No Abstract] [Full Text] [Related]
10. Efalizumab-induced guttate psoriasis. Successful management and re-treatment.
Balato A; La Bella S; Gaudiello F; Balato N
J Dermatolog Treat; 2008; 19(3):182-4. PubMed ID: 18569275
[TBL] [Abstract][Full Text] [Related]
11. Exacerbation of psoriasis under efalizumab therapy.
Rallis E; Verros C; Karanikola E; Valaskatzi A; Papaconstantis M
J Cutan Med Surg; 2009; 13(2):106-9. PubMed ID: 19298780
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation of pityriasis rubra pilaris under efalizumab therapy.
Klein A; Szeimies RM; Landthaler M; Karrer S
Dermatology; 2007; 215(1):72-5. PubMed ID: 17587845
[TBL] [Abstract][Full Text] [Related]
13. Ixekizumab-treatment-emergent photosensitive cutaneous eruption.
Anthony E; Rajgopal Bala H; Goh MS; Balta S; Foley P
Australas J Dermatol; 2018 Nov; 59(4):e284-e286. PubMed ID: 29566260
[No Abstract] [Full Text] [Related]
14. Efalizumab treatment of psoriasis vulgaris: a cohort study in outpatient clinical practice.
Puig L; Roé E; García-Navarro X; Corella F; Alomar A
Clin Exp Dermatol; 2009 Jun; 34(4):469-75. PubMed ID: 19077105
[TBL] [Abstract][Full Text] [Related]
15. The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital.
Antoniou C; Stefanaki I; Stratigos A; Avgerinou G; Stavropoulos P; Potouridou I; Polidorou D; Moustou AE; Kosmadaki M; Katsambas AD
Br J Dermatol; 2007 Apr; 156 Suppl 2():12-6. PubMed ID: 17371318
[TBL] [Abstract][Full Text] [Related]
16. Severe erythroderma in a patient under intermittent therapy with efalizumab.
Hernandez Garcia I
J Drugs Dermatol; 2008 Oct; 7(10):987-9. PubMed ID: 19112767
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.
Menter A; Gordon K; Carey W; Hamilton T; Glazer S; Caro I; Li N; Gulliver W
Arch Dermatol; 2005 Jan; 141(1):31-8. PubMed ID: 15655139
[TBL] [Abstract][Full Text] [Related]
18. Eyelid Dermatitis as a Side Effect of Interleukin-17A Inhibitors in Psoriasis.
Teraki Y; Takahashi A; Inoue Y; Takamura S
Acta Derm Venereol; 2018 Apr; 98(4):456-457. PubMed ID: 29327064
[No Abstract] [Full Text] [Related]
19. [Diffused suberitrodermic psoriasis induced by infliximab].
Bruzzese V
Reumatismo; 2007; 59(4):328-31. PubMed ID: 18157290
[TBL] [Abstract][Full Text] [Related]
20. Clinical considerations of efalizumab therapy in patients with psoriasis.
Hamilton TK
Semin Cutan Med Surg; 2005 Mar; 24(1):19-27. PubMed ID: 15900795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
